Dissemin is shutting down on January 1st, 2025

Published in

American Association for Cancer Research, Cancer Research, 15_Supplement(75), p. 4874-4874, 2015

DOI: 10.1158/1538-7445.am2015-4874

Links

Tools

Export citation

Search in Google Scholar

Abstract 4874: OASIS: A centralized portal for cancer omics data analysis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Advances in cancer research and sequencing technologies have contributed to the proliferation of large-scale cancer omics data sets from both public consortia and privately funded collaborations. There are increasing demands for broadly accessible tools that enable scientists to perform ad hoc analyses of cancer omics data. Here we present OASIS (http://oasis.pfizer.com), an open-access web portal that enables complex analytical queries across somatic mutations, copy number changes (CNV) and gene expression data from public domain and Pfizer funded omics studies. OASIS was designed to perform multidimensional data integration, allowing users to analyze correlations among multiple data types, as well as visualize and compare alterations across different cancers. Users can browse alteration summary reports at the gene and sample level and perform analyses using interactive visualizations. These include the Pan-Cancer Report, a unique tool that provides a high-level overview of genetic variation across multiple cancer types. Through the use of the interactive visualizations researchers can explore differentially expressed genes, identify tumor samples for over expression, investigate the correlation between CNV and expression or survey alteration patterns for a list of genes. Users can explore molecular profiles from the Cancer Cell Line Encyclopedia (CCLE) and the Catalog of Somatic Mutations in Cancer (COSMIC), to identify cell line models of interest. Researchers can also construct complex queries through a user-friendly web interface supported by the Biomart query engine. Programmatic access is also available through web services. OASIS is a powerful tool that enables cancer researchers to perform integrative analyses of large-scale cancer omics data sets, thereby facilitating key steps in oncology drug discovery ranging from target identification to model selection. Citation Format: Julio Fernandez-Banet, Anthony Esposito, Scott Coffin, Sabine Schefzick, Ying Ding, Keith Ching, Istvan Horvath, Peter Roberts, Paul Rejto, Zhengyan Kan. OASIS: A centralized portal for cancer omics data analysis. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4874. doi:10.1158/1538-7445.AM2015-4874